Market Research Report
Sepsis Diagnostics Market Size Analysis Report By Pathogen (Bacterial, Fungal), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Product, By Testing Type, And Segment Forecasts, 2019 - 2026
|Published by||Grand View Research, Inc.||Product code||447139|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Sepsis Diagnostics Market Size Analysis Report By Pathogen (Bacterial, Fungal), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Product, By Testing Type, And Segment Forecasts, 2019 - 2026|
|Published: May 21, 2019||Content info: 110 Pages||
The global sepsis diagnostics market size is expected to reach a value of USD 1.06 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 9.8% during the forecast period. Rising prevalence of sepsis is the most significant factor anticipated to drive the growth.
According to the National Center for Biotechnology Information, the number of patients suffering from septic poisoning increased by an average of 5.7% each year. As a result, there is a rising need for early diagnosis of such blood-poisoning diseases. High prevalence of the disease is also leading to a high mortality rate, triggering early diagnosis for timely clinical intervention.
Rising number of hospital-acquired infections is also expected to support the market growth over the forecast period. Hospital-acquired infections majorly include urinary tract and surgical site infections, which result into septicemia. According to the World Health Organization (WHO), seven out of every 100 hospitalized patients develop hospital-acquired infections in developed countries. Thus, such infections significantly cause septicemia, which will resultantly raise the need for early diagnosis.
On the other hand, pneumonia is also an important driving factor as it is one of the major causes for septic shock. Pneumonia is one of the major causes of sepsis or septic shock. Pneumonia can be a community-acquired disease, which occurs outside the hospital or is sometimes considered as a hospital-acquired disease. According to a study conducted by Centers for Disease Control and Prevention (CDC), nearly 72% patients required hospitalization due to sepsis caused by pneumonia. Moreover, the journal Medical Microbiology also found that more than half of the patients suffering from sepsis had been a victim of pneumonia. Hence, there is a rising need for diagnosis, which in turn produces lucrative opportunities in emerging markets for diagnostic instruments, culture media, and test kits.
Blood culture media was the largest segment in 2018 due to higher adoption of culture media tests in laboratories for the diagnosis of septic poisoning
Molecular diagnostics is anticipated to witness lucrative growth over the forecast period due to quick and efficient identification of microorganisms causing septicemia
Bacterial sepsis held the largest market share in terms of revenue in 2018, due to the fact that bacterial infection is the most common cause of septic poisoning
In 2018, laboratory testing segment held the largest market share due to the fact that majority of the diagnostic tests are conducted in laboratory-based setting
North America led in 2018 owing to the increasing mortality rate of patients suffering from septicemia
Some of the key players operating in the sepsis diagnostics market include bioMerieux SA; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Roche Diagnostics; Cepheid Inc.; Beckman Coulter, Inc.; Nanosphere, Inc.; and Bruker Corporation